Search
    Skip to main content
    Advertisement

    Novartis

    1. Industry Sectors
    2. Pharmaceuticals
    3. Novartis
    Novartis beats on Q2 earnings and sales, CFO retires, stock down Zacks15:40
    Novartis Appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch Retires after 22 Years with the Company Novartis (Press Release)06:09
    Will key drugs maintain momentum for Novartis in Q2 earnings? Zacks15:57
    Why Novartis Is Still A 'Buy' After 15% Surge Seeking Alpha18:05
    NICE recommends Novartis’ Kisqali breast cancer combination therapy Pharmaceutical Field12:53
    Novartis first half net profits up 29 percent France 2411:11
    NICE relents and backs Kisqali for wide use in breast cancer pharmaphorum14:14

    Latest News

    Yesterday
    France’s top court restores collective abuse penalties against Novartis and Roche Global Competition Review16:55 18-Jul-25
    Novartis culls ianalumab in HS after Phase IIb trial failure Clinical Trials Arena11:39 18-Jul-25
    In the last 7 days
    Novartis CEO on pharma tariffs, raised outlook, competition Yahoo! UK & Ireland18:40 17-Jul-25
    Novartis’ Pluvicto finally picks up speed, delivers another trial win in early prostate cancer FiercePharma15:59 17-Jul-25
    Novartis Beats on Q2 Earnings and Sales, CFO Retires, Stock Down Zacks15:40 17-Jul-25
    Compared to Estimates, Novartis (NVS) Q2 Earnings: A Look at Key Metrics Zacks15:30 17-Jul-25
    NICE relents and backs Kisqali for wide use in breast cancer pharmaphorum14:14 17-Jul-25
    Novartis Trims Operating Income Outlook After Strong Q2 Performance, Initiates $10 Billion Stock Buyback Benzinga14:05 17-Jul-25
    Trump & Coca-Cola, Novartis earnings, Netflix preview: Trending Tickers Yahoo! UK & Ireland13:23 17-Jul-25
    NICE recommends Novartis’ Kisqali breast cancer combination therapy Pharmaceutical Field12:53 17-Jul-25
    Novartis’ Kisqali recommended by NICE to treat broad early breast cancer population PMLiVE12:32 17-Jul-25
    Novartis first half net profits up 29 percent France 2411:11 17-Jul-25
    Trending tickers: TSMC, Netflix, Rigetti, Novartis and EasyJet Yahoo! UK & Ireland09:39 17-Jul-25
    Novartis lifts full-year profit forecast, announces $10 billion share buyback Invezz09:16 17-Jul-25
    Novartis Appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch Retires after 22 Years with the Company Novartis (Press Release)06:09 17-Jul-25
    Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating… Novartis (Press Release)06:09 17-Jul-25
    Novartis verzeichnet ein starkes zweites Quartal mit zweistelligem Umsatzwachstum und erhöhter Kerngewinnmarge;… Novartis (Press Release)06:09 17-Jul-25
    Novartis cannot block generic version of Entresto, judge rules The Hindu Business Line05:58 17-Jul-25
    Novartis Denied Bid to Block Generic Entresto In TM Feud Law36021:03 16-Jul-25
    Court Finds MSN Does Not Infringe Novartis’s Patent and Clears the Way for Generic Entresto JD Supra18:29 16-Jul-25
    Will Key Drugs Maintain Momentum for Novartis in Q2 Earnings? Zacks15:57 15-Jul-25
    Why Novartis Is Still A 'Buy' After 15% Surge Seeking Alpha18:05 14-Jul-25
    Exploring Analyst Estimates for Novartis (NVS) Q2 Earnings, Beyond Revenue and EPS Zacks15:21 14-Jul-25
    In the last month
    MSN Beats Novartis' Patent Suit Over Entresto Law36022:51 11-Jul-25
    Novartis Denied in Delaware Bid to Block MSN Copy of Entresto Bloomberg Law16:39 11-Jul-25
    Novartis campaign celebrates teens with spinal muscular atrophy ‘SMAshing’ their limits FiercePharma13:20 11-Jul-25
    Fed. Circ. Backs Novartis PTAB Win Over Shilpa MS Patent Law36001:50 11-Jul-25
    Sironax inks potential $175m deal with Novartis for BBB delivery tech Longevity Technology15:21 10-Jul-25
    Switzerland approves first malaria drug for newborns under 5kg Malay Mail14:09 10-Jul-25
    Novartis Gets Approval for First Malaria Drug for Babies ThisDay Live05:54 10-Jul-25
    Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform While Retaining … PR Newswire (Press Release)13:01 9-Jul-25
    Drug manufacturer Novartis gets nod for first malaria drug to treat babies The Week (India)12:13 9-Jul-25
    First malaria medicine for infants under 4.5kg receives approval Pharmafile11:42 9-Jul-25
    First Malaria treatment for babies approved AfricaNews09:39 9-Jul-25
    Pluvicto enters clinical use in Korea amid growing interest in radioligand therapy for prostate cancer Korea Biomedical Review02:00 9-Jul-25
    Novartis' malaria drug for babies wins world-first approval FiercePharma15:51 8-Jul-25
    Why Novartis (NVS) is a Top Value Stock for the Long-Term Zacks15:41 8-Jul-25
    Novartis wins approval for first malaria drug for newborns and babies Reuters15:17 8-Jul-25
    STAT Plus: Pharmalittle: We’re reading about Medicare drug negotiations, a Novartis malaria… STAT14:30 8-Jul-25
    STAT Plus: Novartis wins approval for newborn malaria treatment STAT14:04 8-Jul-25
    Novartis Secures Approval For First Malaria Therapy for Babies Scrip Pharma Intelligence13:34 8-Jul-25
    Novartis Gets Swiss Approval For First Malaria Drug For Babies Benzinga13:30 8-Jul-25
    New malaria drug to treat babies and young children receives approval The National11:37 8-Jul-25
    Swissmedic approves Novartis’ malaria medicine for babies Pharmaceutical Technology11:35 8-Jul-25
    Novartis receives approval for first malaria medicine for newborn babies and young infants Novartis (Press Release)11:31 8-Jul-25
    First malaria drug for newborns and young infants cleared pharmaphorum11:28 8-Jul-25
    Novartis gets approval for first malaria drug for babies and children The Economic Times07:06 8-Jul-25
    Here's Why Novartis (NVS) is a Strong Momentum Stock Zacks16:03 7-Jul-25
    Novartis’ Cosentyx shows no benefit in Phase III GCA trial Clinical Trials Arena15:47 4-Jul-25
    Novartis’ RED4MS Trial: A New Hope for Multiple Sclerosis Treatment? TipRanks17:27 3-Jul-25
    Novartis' Cosentyx Misses Primary Goal in Arteritis Phase III Study Zacks16:40 3-Jul-25
    Novartis’s Cosentyx Suffers Rare Phase III Fail Scrip Pharma Intelligence16:31 3-Jul-25
    STAT Plus: Pharmalittle: We’re reading about a memo on RFK Jr., a Novartis blockbuster’s failed … STAT14:29 3-Jul-25
    Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trial Benzinga14:25 3-Jul-25
    Novartis drug flunks phase 3 test in giant cell arteritis pharmaphorum11:58 3-Jul-25
    Novartis Blockbuster Antibody Drug Fails in Late-Stage Trial (1) Bloomberg Law10:46 3-Jul-25
    Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA) PR Newswire (Press Release)06:32 3-Jul-25
    Novartis Cites Trial Evidence in Bid to Block MSN Entresto Copy Bloomberg Law18:37 1-Jul-25
    Novartis AG (NVS) Hits Fresh High: Is There Still Room to Run? Zacks15:18 1-Jul-25
    Novartis Sues Aurobindo to Block Copies of Tasigna Leukemia Drug Bloomberg Law20:26 30-Jun-25
    MSN Says Novartis Recycles Arguments to Delay Generic Entresto Bloomberg Law17:33 30-Jun-25
    Regulus Investor Drops Suit After $1.7 Billion Novartis Sale Bloomberg Law17:12 30-Jun-25
    Deal Watch: Novartis To Develop Cardiovascular Therapies With ProFound Scrip Pharma Intelligence19:30 27-Jun-25
    Vernal Keratoconjunctivitis Market Research - Global and Regional Analysis Report 2025-2035… Business Wire (Press Release)12:58 27-Jun-25
    Novartis and ProFound enter cardiovascular disease collaboration worth $750m per target PMLiVE12:37 27-Jun-25
    ProFound Therapeutics announces collaboration with Novartis European Pharmaceutical Manufacturer11:11 27-Jun-25
    Novartis, ProFound Therapeutics Ink Multi-Year Collaboration to Target Cardiovascular Disease Proteins Genetic Engineering and Biotechnology News03:48 27-Jun-25
    Kirkland Stops Repping Novartis After Regeneron Sought DQ Law36001:45 27-Jun-25
    Novartis and Cannes Can: Diversity Collective Team Up To Address Racial Health Disparities Black Enterprise19:34 26-Jun-25
    Kirkland Withdraws From Novartis Case After Regeneron Challenge Bloomberg Law15:59 26-Jun-25
    STAT Plus: The long game for weight loss drugs, allegedly STAT14:36 26-Jun-25
    Novartis concludes Regulus Therapeutics acquisition Pharmaceutical Technology10:11 26-Jun-25
    Novartis: A SWAN Worth Owning Seeking Alpha09:47 26-Jun-25
    Biogen-Ionis Partnered Drug Shows Benefit In Children With Spinal Muscular Atrophy Previously Treated With Novartis'… Benzinga20:04 25-Jun-25
    Regulus Acquired by Novartis, Delisted from Nasdaq TipRanks14:35 25-Jun-25
    Novartis completes acquisition of Regulus Therapeutics Novartis (Press Release)14:29 25-Jun-25
    Novartis announces expiration of Regulus Therapeutics tender offer Novartis (Press Release)06:11 25-Jun-25
    Top Analyst Reports for JPMorgan, Novartis & AT&T Zacks23:00 24-Jun-25
    Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer Novartis (Press Release)06:36 23-Jun-25
    Novartis’ ribociclib approved in Canada for early breast cancer Pharmaceutical Technology14:23 20-Jun-25
    Kirkland’s Regeneron-Novartis Roles Spark Disqualification Bid Bloomberg Law21:07 18-Jun-25
    view more headlines
    18 Jul 16:55

    About our Novartis news

    Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

    Pharmaceuticals Top Stories

    Lupin's arm receives GMP certification from Australia's Tga The Business Standard06:30
    Torrent Pharma seeks CCI nod for ₹19,500 cr majority stake in JB Chemicals The Business Standard05:42
    Third death reported with a Sarepta gene therapy pharmaphorum12:37
    Daiichi Sankyo and AstraZeneca’s Enhertu gains breakthrough therapy status Pharmaceutical Business Review12:48
    Meet the CEO revolutionizing women’s sexual health Women's Health12:16

    UK Top Stories

    Mapped: The UK regions where smoking is most common The Independent12:43UK Weather Met Office England
    Met Office weekend weather: Thunderstorms and downpours dominate the forecast Met Office14:49UK Weather Met Office England
    Diane Abbott suspended again by Labour over racism comments Voice Online19:42Diane Abbott Racism Labour Party
    Minister denies Labour wants Abbott out of party BBC11:51Diane Abbott Racism Labour Party
    ‘In for a shock’: UK to lower voting age to 16 in landmark reform The Sydney Morning Herald01:22UK Politics
    UK government to lower voting age to 16 before next national election despite strong… Fox News18:53UK Politics
    How tragic Somerset bus crash unfolded as one child is killed The Independent09:30Schools Somerset England
    Child who died in school coach crash was 10-year-old boy, police say Sky News15:17Schools Somerset England
    How often your water company dumps sewage in waterways i News21:02Environment Agency Sewage Scandal
    Our failing water firms are a damning reflection of Broken Britain The Independent20:37Environment Agency Sewage Scandal

    World Top Stories

    Trump sues Rupert Murdoch and Wall Street Journal for $10bn after Epstein letter row i News02:30Jeffrey Epstein Donald Trump US
    Trump sues Wall Street Journal for article on note to Epstein Bangkok Post04:11Jeffrey Epstein Donald Trump US
    CEO caught in ‘affair’ at Coldplay concert under investigation New Zealand Herald04:44Astronomy Coldplay Rock
    Astronomer issues statement after CEO caught in Coldplay kiss cam scandal ITV22:01Astronomy Coldplay Rock
    Israel and Syria agree to a ceasefire AsiaOne03:14Israel/Syria Syria Israel
    Israel, Syrian leaders agree to ceasefire, U.S. envoy says CBS News00:52Israel/Syria Syria Israel
    Trump backs Bolsonaro, slams Brazil's regime NewsMax21:49Jair Bolsonaro Brazil South America
    Brazil's Jair Bolsonaro given ankle monitor UPI21:30Jair Bolsonaro Brazil South America
    Trump shocks experts with announcement that undercuts his own legal case The Raw Story22:34El Salvador Venezuela US
    El Salvador and US negotiate prisoner swap with Venezuela BBC21:43El Salvador Venezuela US
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.